Medicare Enrolled
Dr. Pareshkumar Patel, MD
Medical Oncology · Tallahassee, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patel
Dr. Pareshkumar Patel is a medical oncology specialist in Tallahassee, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 34,765 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Patel received a total of $33,728 from 86 pharmaceutical and/or device companies across 592 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 38% volume in FL
$33,728 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 109131 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗34,765
Medicare services
Top 38% in FL for medical oncology
Not available
Unique patients (not deduplicated)
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
11,730 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 10,790 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 3,720 | $18 | $51 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,027 | $0 | $3 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,146 | $8 | $29 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,030 | $1 | $28 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
992 | $8 | $9 |
| Anti-nausea injection (ondansetron/Zofran) | 580 | $0 | $9 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
498 | $96 | $339 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
330 | $97 | $378 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
255 | $22 | $84 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
252 | $12 | $61 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
228 | $10 | $69 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
207 | $62 | $239 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
183 | $45 | $189 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
111 | $1 | $3 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
81 | $1 | $6 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
73 | $49 | $178 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
65 | $42 | $170 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
61 | $2 | $8 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
59 | $27 | $156 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
52 | $21 | $79 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
52 | $3 | $11 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
48 | $2 | $7 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
44 | $10 | $42 |
| New patient office visit, complex (60-74 min) | 24 | $155 | $585 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
24 | $125 | $556 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
23 | $112 | $453 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
23 | $15 | $59 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
23 | $140 | $474 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
17 | $4 | $10 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
17 | $82 | $298 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
36.3% high complexity
54.8% medium
8.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$33,728
Total received (2018-2024)
Avg $4,818/year across 7 years
Top 16% in FL for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
86
Companies
592
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$11,638
2023
$2,024
2022
$1,892
2021
$2,089
2020
$2,157
2019
$4,920
2018
$9,008
Payments by company (2024)
PFIZER INC.
$9,409
Astellas Pharma US Inc
$328
Novartis Pharmaceuticals Corporation
$211
Ipsen Biopharmaceuticals, Inc
$154
GlaxoSmithKline, LLC.
$136
JAZZ PHARMACEUTICALS INC.
$136
Merck Sharp & Dohme LLC
$126
Janssen Biotech, Inc.
$117
Eisai Inc.
$115
AstraZeneca Pharmaceuticals LP
$94
Regeneron Healthcare Solutions, Inc.
$59
Celgene Corporation
$56
Genentech USA, Inc.
$55
Alexion Pharmaceuticals, Inc.
$52
Exelixis Inc.
$44
TAIHO ONCOLOGY, INC.
$40
Pharmacosmos Therapeutics Inc.
$39
SUN PHARMACEUTICAL INDUSTRIES INC.
$39
E.R. Squibb & Sons, L.L.C.
$35
SOBI, INC
$32
SERVIER PHARMACEUTICALS LLC
$30
ARRAY BIOPHARMA INC
$25
Daiichi Sankyo Inc.
$25
Octapharma USA, Inc.
$25
ABBVIE INC.
$24
Blueprint Medicines Corporation
$24
Gilead Sciences, Inc.
$22
PharmaEssentia USA Corporation
$21
Bayer Healthcare Pharmaceuticals Inc.
$21
Incyte Corporation
$21
Stemline Therapeutics Inc.
$20
Lilly USA, LLC
$18
PUMA BIOTECHNOLOGY, INC.
$17
Aveo Pharmaceuticals, Inc.
$17
Alnylam Pharmaceuticals Inc.
$16
Immunocore Limited
$15
Mirati Therapeutics, Inc.
$13
Sirtex Medical Inc
$7
Top 3 companies account for 85.5% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$9,581
Celgene Corporation
$9,203
Verastem, Inc.
$3,073
Rigel Pharmaceuticals, Inc.
$1,032
Seattle Genetics, Inc.
$835
Novartis Pharmaceuticals Corporation
$777
AstraZeneca Pharmaceuticals LP
$765
Astellas Pharma US Inc
$515
E.R. Squibb & Sons, L.L.C.
$468
Genentech USA, Inc.
$431
Merck Sharp & Dohme LLC
$427
JAZZ PHARMACEUTICALS INC.
$416
Regeneron Healthcare Solutions, Inc.
$412
Octapharma USA, Inc.
$396
Janssen Biotech, Inc.
$356
Ipsen Biopharmaceuticals, Inc
$317
Amgen Inc.
$315
Daiichi Sankyo Inc.
$313
GlaxoSmithKline, LLC.
$271
Merck Sharp & Dohme Corporation
$266
Eisai Inc.
$252
Exelixis Inc.
$197
Incyte Corporation
$163
GENZYME CORPORATION
$156
Seagen Inc.
$147
ABBVIE INC.
$143
Alexion Pharmaceuticals, Inc.
$130
Johnson & Johnson Health Care Systems Inc.
$116
ARRAY BIOPHARMA INC
$97
Gilead Sciences, Inc.
$91
Pharmacyclics LLC, An AbbVie Company
$90
Bayer HealthCare Pharmaceuticals Inc.
$88
Pharmacosmos Therapeutics Inc.
$88
Stemline Therapeutics Inc.
$85
Takeda Pharmaceuticals U.S.A., Inc.
$83
AbbVie Inc.
$77
Janssen Pharmaceuticals, Inc
$58
TAIHO ONCOLOGY, INC.
$57
Coherus Biosciences Inc.
$56
PUMA BIOTECHNOLOGY, INC.
$56
AMAG Pharmaceuticals, Inc.
$54
Kite Pharma, Inc.
$53
Blueprint Medicines Corporation
$53
Lexicon Pharmaceuticals, Inc.
$52
SOBI, INC
$50
Karyopharm Therapeutics Inc.
$48
Heron Therapeutics, Inc.
$47
CSL Behring
$47
Boehringer Ingelheim Pharmaceuticals, Inc.
$47
EISAI INC.
$44
Chiesi USA, Inc.
$40
Pharmacyclics LLC, an AbbVie Company
$39
SUN PHARMACEUTICAL INDUSTRIES INC.
$39
Sysmex Inostics Inc
$36
G1 Therapeutics, Inc.
$35
PharmaEssentia USA Corporation
$33
Jazz Pharmaceuticals Inc.
$32
Aveo Pharmaceuticals, Inc.
$32
EMD Serono, Inc.
$31
AbbVie, Inc.
$31
Dendreon Pharmaceuticals LLC
$30
SERVIER PHARMACEUTICALS LLC
$30
Lilly USA, LLC
$30
GE HealthCare
$28
Secura Bio, Inc.
$28
Acrotech Biopharma LLC
$25
Grifols USA, LLC
$25
Bayer Healthcare Pharmaceuticals Inc.
$21
MorphoSys, US Inc.
$21
ImmunoGen, Inc.
$20
CTI BioPharma Corp.
$18
Emmaus Medical, Inc.
$18
Allergan, Inc.
$18
Alnylam Pharmaceuticals Inc.
$16
Deciphera Pharmaceuticals Inc.
$16
Epizyme, Inc.,
$16
Immunocore Limited
$15
Global Blood Therapeutics, Inc.
$14
Clovis Oncology, Inc.
$14
Novo Nordisk Inc
$13
Mirati Therapeutics, Inc.
$13
Nestle HealthCare Nutrition Inc.
$13
Janssen Scientific Affairs, LLC
$13
TG Therapeutics, Inc.
$12
Kyowa Kirin, Inc.
$11
Sirtex Medical Inc
$7
Top 3 companies account for 64.8% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AYVAKIT · Afstyla · Alecensa · Aliqopa · Avastin · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CHANTIX · CINVANTI · COSELA · Cabometyx · Cinvanti · Copiktra · DALVANCE · DARZALEX · Doptelet · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · ENHERTU · ENTRESTO · ERLEADA · Elahere · Endari · Enhertu · Entyvio · Erleada · FARESTON · FERAHEME · FOTIVDA · Fabhalta · Farydak · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · IMJUDO · INJECTAFER · INLYTA · Idelvion · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KENGREAL · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lupron Depot · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · Novoeight · Nplate · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Odomzo · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Padcev · Phesgo · Polivy · Pomalyst · Prolastin-C Liquid · QINLOCK · REBLOZYL · REMICADE · RYDAPT · Revlimid · Rubraca · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TUKYSA · Tavalisse · Tibsovo · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VRAYLAR · Venclexta · Vitrakvi · Vonjo · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · ZEJULA · ZENPEP · ZEPZELCA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
5
County median income
$65,074
Nearest hospital to ZIP centroid (approximate)
TALLAHASSEE MEMORIAL HEALTHCARE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Patel is a mixed practice specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Patel performed 11,730 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $33,728 from 86 companies across 592 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other medical oncologists in Tallahassee?
Dr. Patel's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Tallahassee
Browse medical oncologists in Tallahassee ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Verastem, Inc. Payments to Doctors
See all physicians who received payments from Verastem, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology